Abstract Submission deadline is now passed.
Thank you for submitting your abstract for JSV 2019.
 

To submit an abstract, the following criteria must be met :
 

►The first and presenting author must be a member of the Japanese Society for Virology (JSV). Nonmembers who wish to submit abstracts should join JSV first.
►The JSV membership number is required when you submit an abstract. 
Please put 007-999-9999 if you are in the process of joining JSV members.
►JSV membership is not necessarily required for those who belong to overseas facilities.
►International students in Japan should join JSV membership if they wish to submit abstracts.
►Join JSV membership through the website of The Japanese Society for Virology

*Inquiry about JSV membership The Japanese Society for Virology c/o Microbiological Science, Inc. 4-13-18 Koishikawa, Bunkyo-ku, Tokyo 112-0002, Japan E-mail：biseibutsu-com@umin.ac.jp

 

1. Presentation Style/Language
1) Workshop・Oral ・Presentation time ･･･English
2) Poster ･･･English or Japanese

Presentation Style	Abstract Title(*1)	Abstract Text	Authors(*1)	Affiliations(*1)	presentation time / Q&A (*2)
Workshop	English and Japanese	English	English and Japanese	English and Japanese	15min/5min
Oral	English and Japanese	English	English and Japanese	English and Japanese	12min/3min
Poster	English and Japanese	English or Japanese	English and Japanese	English and Japanese	―

*1: Japanese authors are requested to put both Japanese and English.
*2: The presentation time may be changed depending on the number of applicants.

2. How to submit an abstract
►All abstracts should be submitted electronically through Online Abstract Submission System, Confit.
*Abstracts should not be submitted by post or e-mail.
*Browser to be used are;
 •Microsoft Edge (latest version) / •Internet Explorer (latest version)
 •Firefox (latest version) / •Safari (latest version) / •Chrome (latest version)

►Abstract text should be structured as follows: Objectives - Methods - Results - Discussion.
►Abstract title and text are within140 characters, and 2,000 characters reservedly.
►Please retain your login ID and  password (you set your own login ID whithin 32 characters, and password between 8 and 32 characters long).
For security reasons, the secretariat is not arrowed to respond to inquiries concerning ID and passwords.

3. Abstract Category

Within each category (A, B, and C), please select the topic most suitable topics for your presentation.

［A］			［C］
A01	Retroviruses		C01	Plant viruses
A02	Orthomyxoviruses		C02	Insect viruses
A03	Hepatitis Viruses(HAV, HBV, HCV, HDV and HEV)		C03	Adenoviridae
A04	DNA viruses		C04	Alphaherpesvirinae
A05	Positive strand RNA viruses		C05	Arenaviridae
A06	Negative strand and ambisense RNA viruses		C06	Astroviridae
A07	Double-stranded RNA viruses		C07	Asfarviridae
A08	Others(including prions, viroids and phages)		C08	Betaherpesvirinae
			C09	Bornaviridae
［B］			C10-1	Hantaviridae
B01	Structure		C10-2	Phenuiviridae
B02	Virus entry		C10-3	Nairoviridae
B03	Genome and gene expression		C11	Caliciviridae
B04	Assembly and release		C12	Coronaviridae
B05	Replication of genome		C13	Filoviridae
B06	Viral spread and transmission		C14	Flaviviridae
B07	Pathogenesis		C15	Gammaherpesvirinae
B08	Oncogenesis		C16	Hepadnaviridae
B09	Epidemiology		C17	Hepeviridae
B10	Diversity and evolution		C18	Orthomyxoviridae
B11	Innate immunity		C19	Papillomaviridae
B12	Acquired immunity and vaccines		C20	Paramyxoviridae
B13	Antivirals		C21	Parvoviridae
B14	Gene therapy and viral vectors		C22	Picornaviridae
B15	Data analysis and mathematical model		C23	Polyomaviridae
			C24	Poxviridae
			C25	Reoviridae
			C26	Retroviridae (Lentivirus)
			C27	Retroviridae (except for Lentivirus)
			C28	Rhabdoviridae
			C29	Togaviridae
			C30	Others

4. Notice
►It is not permitted to present the same abstract at a scientific meeting as the one already published in scientific journals.
►One abstract will be accepted per presenter (first author).
►Co-authors are eligible to submit more than one abstract.
►Only one abstract will be accepted when the abstracts from the same group are obviously considered as one presentation.
►Please include the latest research result.
►The following abstracts will not be accepted: aim of study is not clear, irrelevant replication research, containing significant errors, gap between experiment and conclusion, and lack in moral consideration, etc.
 

►The program committee is responsible for reviewing all abstracts and deciding presentation style and time. If you have not received an e-mail notification, please contact the meeting secretariat.
►Notification regarding acceptance or rejection will be sent to the submitting authors’e-mail address by the end of August, 2019.
 

 

Secretariat（c/o BlueRidge, Inc.） Nishiazabu 3-1-17, Minato-ku, Tokyo 106-0031, Japan Email：jsv67@blue-ridge.jp